Tumor Vasculatures

A New Target for Cancer Immunotherapy

Zhigang Liu, Y. Wang, Y. Huang, Y S Betty Kim, Hong Shan, D. Wu, Wen Jiang

Research output: Contribution to journalReview article

Abstract

Immune cells rely on a functional vascular network to enter tissues. In solid tumors, blood vessels are abnormal and dysfunctional and, thus, immune effector cell infiltration is impaired. Although normalizing the tumor vasculature has been shown to improve the efficacy of cancer immunotherapies, recent studies suggest that enhanced immune stimulation also, in turn, improves tumor vascular normalization. Thus, this new paradigm of immune system–tumor vasculature mutual reprogramming opens the possibility of identifying new cancer treatment strategies that combine vascular targeting and immunotherapies. Here, we highlight current evidence supporting immune system–tumor vasculature crosstalk and outline how this relationship can provide new rationales for developing more effective combination immunotherapy strategies for treating human cancers.

Original languageEnglish (US)
JournalTrends in Pharmacological Sciences
DOIs
StatePublished - Jan 1 2019

Fingerprint

Immunotherapy
Tumors
Blood Vessels
Neoplasms
Oncology
Blood vessels
Crosstalk
Infiltration
Vascular Tissue Neoplasms
Tissue
Therapeutics

Keywords

  • cancer immunotherapy
  • immune checkpoint blockade
  • tumor microenvironment
  • tumor vasculature
  • vascular normalization

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Tumor Vasculatures : A New Target for Cancer Immunotherapy. / Liu, Zhigang; Wang, Y.; Huang, Y.; Kim, Y S Betty; Shan, Hong; Wu, D.; Jiang, Wen.

In: Trends in Pharmacological Sciences, 01.01.2019.

Research output: Contribution to journalReview article

Liu, Zhigang ; Wang, Y. ; Huang, Y. ; Kim, Y S Betty ; Shan, Hong ; Wu, D. ; Jiang, Wen. / Tumor Vasculatures : A New Target for Cancer Immunotherapy. In: Trends in Pharmacological Sciences. 2019.
@article{4ca155dd6af0462c9c94da59848e9fef,
title = "Tumor Vasculatures: A New Target for Cancer Immunotherapy",
abstract = "Immune cells rely on a functional vascular network to enter tissues. In solid tumors, blood vessels are abnormal and dysfunctional and, thus, immune effector cell infiltration is impaired. Although normalizing the tumor vasculature has been shown to improve the efficacy of cancer immunotherapies, recent studies suggest that enhanced immune stimulation also, in turn, improves tumor vascular normalization. Thus, this new paradigm of immune system–tumor vasculature mutual reprogramming opens the possibility of identifying new cancer treatment strategies that combine vascular targeting and immunotherapies. Here, we highlight current evidence supporting immune system–tumor vasculature crosstalk and outline how this relationship can provide new rationales for developing more effective combination immunotherapy strategies for treating human cancers.",
keywords = "cancer immunotherapy, immune checkpoint blockade, tumor microenvironment, tumor vasculature, vascular normalization",
author = "Zhigang Liu and Y. Wang and Y. Huang and Kim, {Y S Betty} and Hong Shan and D. Wu and Wen Jiang",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.tips.2019.07.001",
language = "English (US)",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Tumor Vasculatures

T2 - A New Target for Cancer Immunotherapy

AU - Liu, Zhigang

AU - Wang, Y.

AU - Huang, Y.

AU - Kim, Y S Betty

AU - Shan, Hong

AU - Wu, D.

AU - Jiang, Wen

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Immune cells rely on a functional vascular network to enter tissues. In solid tumors, blood vessels are abnormal and dysfunctional and, thus, immune effector cell infiltration is impaired. Although normalizing the tumor vasculature has been shown to improve the efficacy of cancer immunotherapies, recent studies suggest that enhanced immune stimulation also, in turn, improves tumor vascular normalization. Thus, this new paradigm of immune system–tumor vasculature mutual reprogramming opens the possibility of identifying new cancer treatment strategies that combine vascular targeting and immunotherapies. Here, we highlight current evidence supporting immune system–tumor vasculature crosstalk and outline how this relationship can provide new rationales for developing more effective combination immunotherapy strategies for treating human cancers.

AB - Immune cells rely on a functional vascular network to enter tissues. In solid tumors, blood vessels are abnormal and dysfunctional and, thus, immune effector cell infiltration is impaired. Although normalizing the tumor vasculature has been shown to improve the efficacy of cancer immunotherapies, recent studies suggest that enhanced immune stimulation also, in turn, improves tumor vascular normalization. Thus, this new paradigm of immune system–tumor vasculature mutual reprogramming opens the possibility of identifying new cancer treatment strategies that combine vascular targeting and immunotherapies. Here, we highlight current evidence supporting immune system–tumor vasculature crosstalk and outline how this relationship can provide new rationales for developing more effective combination immunotherapy strategies for treating human cancers.

KW - cancer immunotherapy

KW - immune checkpoint blockade

KW - tumor microenvironment

KW - tumor vasculature

KW - vascular normalization

UR - http://www.scopus.com/inward/record.url?scp=85069602962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069602962&partnerID=8YFLogxK

U2 - 10.1016/j.tips.2019.07.001

DO - 10.1016/j.tips.2019.07.001

M3 - Review article

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

ER -